文献速递脊柱关节炎类风湿关节炎

更新马德里超声附着点指数(MASEI)的应用:一项系统综述

Updating the use of the Madrid Sonographic Enthesis Index (MASEI): a systematic review of the literature.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究系统检索 MEDLINE、EMBASE 和 Cochrane 数据库,评估 MASEI 自发表以来的使用情况。MASEI 在可行性、信度和结构效度方面有报道,但无研究评估治疗反应性。

要点

  • MASEI 主要用于脊柱关节炎(12/27 篇,44%)和银屑病关节炎/类风湿关节炎(5/27 篇,19%)。
  • 信度在 12 篇(44%)中报道,值为良好至优秀;可行性在 3 篇(11%)中报道。
  • 无研究评估 MASEI 对治疗的反应性。

核心结论

  • MASEI 是用于脊柱关节炎、银屑病关节炎及其他疾病附着点研究的可行、可靠且有效的超声评分。

研究设计与样本

  • 系统综述,检索 MEDLINE、EMBASE 和 Cochrane Central Register 数据库,仅纳入人类研究,由一名评价者筛选、第二名评价者核实。

主要发现

  • 27 篇全文中,MASEI 主要用于脊柱关节炎及相关疾病(12 篇,44%),其次为银屑病关节炎和类风湿关节炎(各 5 篇,19%),也用于白塞病、纤维肌痛、家族性地中海热、干燥综合征、晶体性关节病和系统性硬化症。
  • 可行性在 3 篇(11%)中报道,信度在 12 篇(44%)中报道且值为良好至优秀,无文章评估治疗反应性。
  • 结构效度通过生物标志物评估 7 篇(26%)、临床检查 13 篇(48%)、影像学(仅 X 线)2 篇(7%);判别效度在 16 篇(59%)中评估。

关键数值与推荐

  • MASEI 信度报道值为良好至优秀(12 篇,44%)。
  • 结构效度评估:生物标志物 7 篇(26%),临床检查 13 篇(48%),X 线 2 篇(7%)。
  • 判别效度在 16 篇(59%)中评估,不限于脊柱关节炎。

临床怎么用

  • MASEI 可作为脊柱关节炎、银屑病关节炎等疾病附着点评估的可靠超声评分工具。
  • 目前缺乏 MASEI 对治疗反应性的证据,临床用于监测治疗反应时需谨慎。

局限性

  • 无研究评估 MASEI 对治疗的反应性。
  • 纳入研究中 60% 为摘要,全文仅 40%,可能影响数据完整性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a systematic review of the literature to evaluate the use of the enthesis ultrasound Madrid Sonographic Entesis Index (MASEI) from its publication. METHODS: A systematic search of MEDLINE, EMBASE, and Cochrane Central Register databases was performed. The search strategy was constructed to identify publications containing terms related to enthesis and ultrasound. The only applied filter was studies conducted in humans. One reviewer systematically screened the search. A second reviewer verified the selection. The data extraction was focused on study characteristics, including population and components of the OMERACT filter. RESULTS: Sixty-eight of the 1581 identified studies had used MASEI, including 41 (60%) abstracts and 27 (40%) articles. Of the 27 articles, MASEI was mainly used for spondyloarthritis and related diseases in 12 (44%) articles, followed by both psoriatic arthritis and rheumatoid arthritis in five (19%) articles; however, it was also used in diseases such as Behçet disease, FM, familiar Mediterranean fever, SS, crystal arthropathies and systemic sclerosis. The feasibility of MASEI was reported in three (11%) articles, and the reliability in 12 (44%) with good to excellent values. No article evaluated the responsiveness to treatment. The construct validity of MASEI was assessed using biomarkers in seven (26%) articles, clinical examination in 13 (48%) and imaging procedures (only X-rays) in two (7%). The discriminative validity was assessed in 16 (59%) articles, not only in SpAs. CONCLUSION: MASEI is a feasible, reliable and valid ultrasound score for the study of enthesis in spondyloarthritis, psoriatic arthritis and other diseases.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Macía-Villa C, De Miguel E. Updating the use of the Madrid Sonographic Enthesis Index (MASEI): a systematic review of the literature. Rheumatology (Oxford). 2020. PMID: 31750519. doi:10.1093/rheumatology/kez356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。